Skip to main content
. Author manuscript; available in PMC: 2013 Aug 17.
Published in final edited form as: J Cardiovasc Pharmacol. 2009 Jul;54(1):63–71. doi: 10.1097/FJC.0b013e3181abc288

FIGURE 3.

FIGURE 3

Anti-OCTN1 immunos-taining in human atrium. (A) With antibody. Note the absence of chromagen staining on the blood vessel. (B) An atrial tissue sample treated with the secondary antibody alone as a negative control. (C) Healthy human kidney with antibody. (D) Negative control with healthy human kidney. Background hematoxylin stain was used for all four experiments.